EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms

被引:63
|
作者
van Lengerich, Bettina [1 ]
Agnew, Christopher [1 ]
Puchner, Elias M. [2 ]
Huang, Bo [3 ,4 ]
Jura, Natalia [1 ,5 ]
机构
[1] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA
[2] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA
[3] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA
[5] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA
基金
美国国家卫生研究院;
关键词
HER/ERBB receptors; receptor tyrosine kinase signaling; receptor clustering; STORM; EGFR activation; EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; HIGHER-ORDER OLIGOMERS; CELL-SURFACE; LIVING CELLS; NANOCLUSTER FORMATION; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; ERBB RECEPTORS; LUNG-CANCER;
D O I
10.1073/pnas.1617994114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Heteromeric interactions between the catalytically impaired human epidermal growth factor receptor (HER3/ERBB3) and its catalytically active homologs EGFR and HER2 are essential for their signaling. Different ligands can activate these receptor pairs but lead to divergent signaling outcomes through mechanisms that remain largely unknown. We used stochastic optical reconstruction microscopy (STORM) with pair-correlation analysis to show that EGF and neuregulin (NRG) can induce different extents of HER3 clustering that are dependent on the nature of the coexpressed HER receptor. We found that the presence of these clusters correlated with distinct patterns and mechanisms of receptor phosphorylation. NRG induction of HER3 phosphorylation depended on the formation of the asymmetric kinase dimer with EGFR in the absence of detectable higher-order oligomers. Upon EGF stimulation, HER3 paralleled previously observed EGFR behavior and formed large clusters within which HER3 was phosphorylated via a noncanonical mechanism. HER3 phosphorylation by HER2 in the presence of NRG proceeded through still another mechanism and involved the formation of clusters within which receptor phosphorylation depended on asymmetric kinase dimerization. Our results demonstrate that the higher-order organization of HER receptors is an essential feature of their ligand-induced behavior and plays an essential role in lateral cross-activation of the receptors. We also show that HER receptor ligands exert unique effects on signaling by modulating this behavior.
引用
收藏
页码:E2836 / E2845
页数:10
相关论文
共 50 条
  • [31] Roles and mechanisms of NRG1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG1 modulates NAFLD through ErbB3 signaling)
    Meng, Di
    Pan, Hongying
    Chen, Youwei
    Ding, Jiexia
    Dai, Yining
    OBESITY RESEARCH & CLINICAL PRACTICE, 2021, 15 (02) : 145 - 151
  • [32] A NOVEL HER3/ERBB3 DRIVER MUTATION IN NON-SMALL CELL LUNG CANCER
    Umelo, I. A.
    Noeparast, A.
    Chen, G.
    Renard, M.
    Geers, C.
    Vansteenkiste, J.
    Teugels, E.
    de Greve, J.
    ANNALS OF ONCOLOGY, 2013, 24 : 13 - 14
  • [33] The immunoglobulin-like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation
    Centa, Ariana
    Rodriguez-Barrueco, Ruth
    Carlos Montero, Juan
    Pandiella, Atanasio
    MOLECULAR ONCOLOGY, 2018, 12 (07): : 1061 - 1076
  • [34] Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
    Garrett, Joan T.
    Olivares, Maria Graciela
    Rinehart, Cammie
    Granja-Ingram, Nara D.
    Sanchez, Violeta
    Chakrabarty, Anindita
    Dave, Bhuvanesh
    Cook, Rebecca S.
    Pao, William
    McKinely, Eliot
    Manning, H. C.
    Chang, Jenny
    Arteaga, Carlos L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) : 5021 - 5026
  • [35] The Role of HER3 (erbB3) Overexpression in Peripheral Nerve Sheath Tumors (PNST) as a New Therapeutic Target
    Romagosa, C.
    Teixido, C.
    Garcina, A.
    Simonetti, S.
    Moline, T.
    Hernandez-Losa, J.
    Ramon y Cajal, S.
    LABORATORY INVESTIGATION, 2013, 93 : 19A - 19A
  • [36] The Role of HER3 (erbB3) Overexpression in Peripheral Nerve Sheath Tumors (PNST) as a New Therapeutic Target
    Romagosa, C.
    Teixido, C.
    Garcina, A.
    Simonetti, S.
    Moline, T.
    Hernandez-Losa, J.
    Ramon y Cajal, S.
    MODERN PATHOLOGY, 2013, 26 : 19A - 19A
  • [37] Upregulation of HER3 (ErbB3) levels and function counteracts the antitumor effect of HER2 and PI3K inhibitors
    Garrett, Joan
    Rinehart, Cammie
    Chakrabarty, Anindita
    Dave, Bhuvanesh
    Pao, William
    Manning, Charles
    Chang, Jenny
    Arteagal, Carlos
    CANCER RESEARCH, 2011, 71
  • [38] Overexpression of c-Src enhances HER2/Neu/ErbB2 and HER3/ErbB3 heterocomplex formation and its function
    Miyake, Tsuyoshi
    Ishizawar, Rumey C.
    Parsons, Sarah J.
    CANCER RESEARCH, 2006, 66 (08)
  • [39] The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling
    Z Huang
    B-K Choi
    K Mujoo
    X Fan
    M Fa
    S Mukherjee
    N Owiti
    N Zhang
    Z An
    Oncogene, 2015, 34 : 1105 - 1115
  • [40] Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors
    Chakrabarty, Anindita
    Sanchez, Violeta
    Kuba, Maria G.
    Rinehart, Cammie
    Arteaga, Carlos L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (08) : 2718 - 2723